Logo image of ASST

ASSET ENTITIES INC-B (ASST) Stock Fundamental Analysis

NASDAQ:ASST - Nasdaq - US04541A2042 - Common Stock - Currency: USD

0.6573  +0.06 (+10.45%)

After market: 0.627 -0.03 (-4.61%)

Fundamental Rating

2

Overall ASST gets a fundamental rating of 2 out of 10. We evaluated ASST against 93 industry peers in the Media industry. While ASST seems to be doing ok healthwise, there are quite some concerns on its profitability. ASST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ASST has reported negative net income.
ASST had a negative operating cash flow in the past year.
ASST Yearly Net Income VS EBIT VS OCF VS FCFASST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

ASST has a worse Return On Assets (-231.10%) than 98.85% of its industry peers.
With a Return On Equity value of -269.53%, ASST is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -231.1%
ROE -269.53%
ROIC N/A
ROA(3y)-102.66%
ROA(5y)N/A
ROE(3y)-184.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASST Yearly ROA, ROE, ROICASST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

ASST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASST Yearly Profit, Operating, Gross MarginsASST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -500 -1K -1.5K

5

2. Health

2.1 Basic Checks

ASST does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASST has been increased compared to 1 year ago.
The debt/assets ratio for ASST has been reduced compared to a year ago.
ASST Yearly Shares OutstandingASST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
ASST Yearly Total Debt VS Total AssetsASST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -5.51, we must say that ASST is in the distress zone and has some risk of bankruptcy.
ASST has a Altman-Z score of -5.51. This is amonst the worse of the industry: ASST underperforms 90.80% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ASST is not too dependend on debt financing.
ASST has a better Debt to Equity ratio (0.17) than 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -5.51
ROIC/WACCN/A
WACC8.91%
ASST Yearly LT Debt VS Equity VS FCFASST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M

2.3 Liquidity

A Current Ratio of 6.05 indicates that ASST has no problem at all paying its short term obligations.
The Current ratio of ASST (6.05) is better than 97.70% of its industry peers.
ASST has a Quick Ratio of 6.05. This indicates that ASST is financially healthy and has no problem in meeting its short term obligations.
ASST has a better Quick ratio (6.05) than 97.70% of its industry peers.
Industry RankSector Rank
Current Ratio 6.05
Quick Ratio 6.05
ASST Yearly Current Assets VS Current LiabilitesASST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

3

3. Growth

3.1 Past

The earnings per share for ASST have decreased strongly by -709.87% in the last year.
ASST shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.95%.
The Revenue has been growing by 47.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-709.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-505.42%
Revenue 1Y (TTM)27.95%
Revenue growth 3Y47.18%
Revenue growth 5YN/A
Sales Q2Q%24.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASST Yearly Revenue VS EstimatesASST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 200K 400K 600K 800K
ASST Yearly EPS VS EstimatesASST Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASST. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASST Price Earnings VS Forward Price EarningsASST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASST Per share dataASST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ASST!.
Industry RankSector Rank
Dividend Yield N/A

ASSET ENTITIES INC-B

NASDAQ:ASST (2/21/2025, 8:02:00 PM)

After market: 0.627 -0.03 (-4.61%)

0.6573

+0.06 (+10.45%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.7%
Inst Owner Change812.72%
Ins Owners17.47%
Ins Owner Change8.3%
Market Cap3.90M
AnalystsN/A
Price TargetN/A
Short Float %4.15%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.86
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 2.18
EV/EBITDA N/A
EPS(TTM)-1.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS0.06
BVpS0.35
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -231.1%
ROE -269.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-102.66%
ROA(5y)N/A
ROE(3y)-184.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.05
Quick Ratio 6.05
Altman-Z -5.51
F-Score3
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-709.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-505.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.95%
Revenue growth 3Y47.18%
Revenue growth 5YN/A
Sales Q2Q%24.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-108.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-550.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-531.62%
OCF growth 3YN/A
OCF growth 5YN/A